MovDisordV3, Main, Exploration, bibRecord, 002124

Pregabalin‐ and gabapentin‐associated myoclonus in a patient with chronic renal failure

Identifieur interne : 002124 ( Main/Exploration ); précédent : 002123; suivant : 002125

Pregabalin‐ and gabapentin‐associated myoclonus in a patient with chronic renal failure

Auteurs : Daniel G. Healy [Royaume-Uni] ; Gordon T. Ingle [Royaume-Uni] ; Peter Brown [Royaume-Uni]

Source :

Movement Disorders [ 0885-3185 ] ; 2009-10-15.

RBID : ISTEX:3F9E5F21F396634F9F9FABB5B6C08C74DA735032

English descriptors

KwdEn :
- Amines (adverse effects), Anticonvulsants (adverse effects), Cyclohexanecarboxylic Acids (adverse effects), Humans, Kidney Failure, Chronic (drug therapy), Male, Middle Aged, Myoclonus (chemically induced), gamma-Aminobutyric Acid (adverse effects), gamma-Aminobutyric Acid (analogs & derivatives).
MESH :
- chemical , adverse effects : Amines, Anticonvulsants, Cyclohexanecarboxylic Acids, gamma-Aminobutyric Acid.
- chemical , analogs & derivatives : gamma-Aminobutyric Acid.
- chemically induced : Myoclonus.
- drug therapy : Kidney Failure, Chronic.
- Humans, Male, Middle Aged.

Url:

https://api.istex.fr/document/3F9E5F21F396634F9F9FABB5B6C08C74DA735032/fulltext/pdf

DOI: 10.1002/mds.22286

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pregabalin‐ and gabapentin‐associated myoclonus in a patient with chronic renal failure</title>
<author><name sortKey="Healy, Daniel G" sort="Healy, Daniel G" uniqKey="Healy D" first="Daniel G." last="Healy">Daniel G. Healy</name>
</author>
<author><name sortKey="Ingle, Gordon T" sort="Ingle, Gordon T" uniqKey="Ingle G" first="Gordon T." last="Ingle">Gordon T. Ingle</name>
</author>
<author><name sortKey="Brown, Peter" sort="Brown, Peter" uniqKey="Brown P" first="Peter" last="Brown">Peter Brown</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3F9E5F21F396634F9F9FABB5B6C08C74DA735032</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/mds.22286</idno>
<idno type="url">https://api.istex.fr/document/3F9E5F21F396634F9F9FABB5B6C08C74DA735032/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002520</idno>
<idno type="wicri:Area/Istex/Curation">002520</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D26</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Healy D:pregabalin:and:gabapentin</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19642217</idno>
<idno type="wicri:Area/PubMed/Corpus">001C16</idno>
<idno type="wicri:Area/PubMed/Curation">001C16</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C31</idno>
<idno type="wicri:Area/Ncbi/Merge">002761</idno>
<idno type="wicri:Area/Ncbi/Curation">002761</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002761</idno>
<idno type="wicri:Area/Main/Merge">002985</idno>
<idno type="wicri:Area/Main/Curation">002124</idno>
<idno type="wicri:Area/Main/Exploration">002124</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Pregabalin‐ and gabapentin‐associated myoclonus in a patient with chronic renal failure</title>
<author><name sortKey="Healy, Daniel G" sort="Healy, Daniel G" uniqKey="Healy D" first="Daniel G." last="Healy">Daniel G. Healy</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences, Institute of Neurology, University College London, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ingle, Gordon T" sort="Ingle, Gordon T" uniqKey="Ingle G" first="Gordon T." last="Ingle">Gordon T. Ingle</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>NMR Research Unit, Institute of Neurology, University College London, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Brown, Peter" sort="Brown, Peter" uniqKey="Brown P" first="Peter" last="Brown">Peter Brown</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009-10-15">2009-10-15</date>
<biblScope unit="vol">24</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="2028">2028</biblScope>
<biblScope unit="page" to="2029">2029</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">3F9E5F21F396634F9F9FABB5B6C08C74DA735032</idno>
<idno type="DOI">10.1002/mds.22286</idno>
<idno type="ArticleID">MDS22286</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amines (adverse effects)</term>
<term>Anticonvulsants (adverse effects)</term>
<term>Cyclohexanecarboxylic Acids (adverse effects)</term>
<term>Humans</term>
<term>Kidney Failure, Chronic (drug therapy)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Myoclonus (chemically induced)</term>
<term>gamma-Aminobutyric Acid (adverse effects)</term>
<term>gamma-Aminobutyric Acid (analogs & derivatives)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Amines</term>
<term>Anticonvulsants</term>
<term>Cyclohexanecarboxylic Acids</term>
<term>gamma-Aminobutyric Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>gamma-Aminobutyric Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Myoclonus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Kidney Failure, Chronic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Healy, Daniel G" sort="Healy, Daniel G" uniqKey="Healy D" first="Daniel G." last="Healy">Daniel G. Healy</name>
</region>
<name sortKey="Brown, Peter" sort="Brown, Peter" uniqKey="Brown P" first="Peter" last="Brown">Peter Brown</name>
<name sortKey="Ingle, Gordon T" sort="Ingle, Gordon T" uniqKey="Ingle G" first="Gordon T." last="Ingle">Gordon T. Ingle</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002124 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002124 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:3F9E5F21F396634F9F9FABB5B6C08C74DA735032
   |texte=   Pregabalin‐ and gabapentin‐associated myoclonus in a patient with chronic renal failure
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Pregabalin‐ and gabapentin‐associated myoclonus in a patient with chronic renal failure

Pregabalin‐ and gabapentin‐associated myoclonus in a patient with chronic renal failure

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.